Metastatic Hepatic Epithelioid Hemangioendothelioma Treated With Olaratumab: A Falling Star Rising?
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s220804
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Informa UK Limited